tirzepatide updates today FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly tirzepatide fda update Compounded Tirzepatide

Compare against your baseline

While oral tirzepatide options and orally disintegrating tablets are emerging, subcutaneous injection with a syringe continues to deliver the most reliable absorption and outcomes

If you have type 2 diabetes, you may need higher doses or more time to achieve the same degree of appetite suppression as someone without diabetes

"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist"

A simple log of injection sites and side effects helps you identify what works for your body

The tirzepatide dosage in units guide can help you map out exactly how many doses each vial contains